Blood protein may reveal hidden nerve damage in diabetes and fatty liver
NCT ID NCT07663682
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study investigates whether a substance in the blood called nociceptin is linked to overactive nerves in people who have both type 2 diabetes and metabolic fatty liver disease. Researchers will compare 50 patients with both conditions to 50 healthy volunteers, measuring nociceptin and a marker of nerve activity from a single blood sample. The goal is to see if nociceptin could serve as a simple biomarker for this common health problem. No treatments or experimental drugs are involved.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If a link is found, nociceptin could become a simple blood test to help diagnose or monitor this common combination of conditions.
What could go wrong
This is a small, early-stage observational study, not a treatment trial. It may find no meaningful correlation, and results may not apply to broader populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Second Hospital of Shanxi Medical University
Taiyuan, Shanxi, 030001, China